User account menu Search Menu Home About Strategy Strategy Our strategy is to build a leading, focused medicines company powered by advanced therapy platforms and data science. Strategic priorities As we implement our strategy, we have five priorities to shape our future and help us continue to create value for our company, our shareholders and society. Unleash the power of our people We are transforming our culture to ensure people can fully apply their talent and energy. We’re creating an organization where people are inspired, curious and unbossed. Learn More Deliver transformative innovation In our pursuit of transformative treatments, we challenge medical paradigms and explore possibilities to cure disease, intervene earlier in chronic illnesses, and find ways to dramatically improve quality of life. Learn More Embrace operational excellence We are rethinking how we work, embracing agile teams and building better productivity into our company to free resources that we can invest in innovation and help boost returns. Go big on data and digital We aim to spark a digital revolution at Novartis, embracing digital technologies, advanced analytics and artificial intelligence to help drive innovation and improve efficiency. Learn More Build trust with society We strive to build trust with society through our efforts to operate with high values and integrity, and to find new ways to expand patients’ access to our treatments. Learn More Related Links Careers in Strategy A visual tour of scientific strategies for combating coronavirus Novartis announces new strategy to provide innovative medicines to more patients in sub-Saharan Africa Alcon to highlight its vision, strategy and benefits as a standalone company to investors and analysts in New York and London Novartis Navigate Patients and Caregivers Healthcare Professionals Researchers Job Seekers Journalists Investors Partners Suppliers Topics Clinical Trials COVID-19 Info Center ESG Explore Stories Diseases Locations Companies Sandoz Advanced Accelerator Applications Footer Bottom © 2021 Novartis AG Terms of Use Privacy Contacts Cookie Settings Site Map Novartis Site Directory This site is intended for a global audience